The in vitro data confirmed that our BDNF AntagoNAT constructs encapsulated in liposomes are capable of inducing both BDNF transcription and translation in BDNF NAT-expressing rat schwannoma cells at 48 h. Here, BRD2 is linked to schwannoma.